1. Home
  2. GEG vs HRTX Comparison

GEG vs HRTX Comparison

Compare GEG & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Great Elm Group Inc.

GEG

Great Elm Group Inc.

N/A

Current Price

$2.15

Market Cap

63.9M

Sector

Technology

ML Signal

N/A

Logo Heron Therapeutics Inc.

HRTX

Heron Therapeutics Inc.

N/A

Current Price

$0.36

Market Cap

54.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GEG
HRTX
Founded
1994
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
63.9M
54.1M
IPO Year
2022
2007

Fundamental Metrics

Financial Performance
Metric
GEG
HRTX
Price
$2.15
$0.36
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
N/A
AVG Volume (30 Days)
5.1K
★ 4.2M
Earning Date
11-04-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
$67,974,000.00
★ $154,904,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$4.82
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 11.70
7.36
52 Week Low
$1.80
$0.26
52 Week High
$2.83
$1.58

Technical Indicators

Market Signals
Indicator
GEG
HRTX
Relative Strength Index (RSI) 47.70 56.68
Support Level $2.14 $0.30
Resistance Level $2.22 $0.44
Average True Range (ATR) 0.03 0.03
MACD -0.00 0.01
Stochastic Oscillator 33.33 61.25

Price Performance

Historical Comparison
GEG
HRTX

About GEG Great Elm Group Inc.

Great Elm Group Inc operates as an alternative asset manager focused on growing a scalable and diversified portfolio of long-duration and permanent capital vehicles across credit, real estate, specialty finance, and other alternative strategies. The Group conducts its operations through two business segments: Alternative Credit and Real Estate. Key revenue comes from the Real Estate segment, which includes a full-service, end-to-end real estate platform combining investment expertise and turnkey execution capabilities for the IOS sector. The Alternative Credit segment focuses on income generation and capital preservation by investing in debt and income-generating securities, direct lending, CLOs, and specialty finance businesses, including factoring, asset-based lending, and healthcare.

About HRTX Heron Therapeutics Inc.

Heron Therapeutics Inc is a commercial-stage biotechnology company. The company is focused on improving the lives of patients by developing treatments and commercializing therapeutic solutions to address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.

Share on Social Networks: